Vensana Capital Launches Vensana Innovation and Adds Thomas Tu, MD, as Venture Partner [Yahoo! Finance]
CVRx, Inc. (CVRX)
Company Research
Source: Yahoo! Finance
MINNEAPOLIS & WASHINGTON, October 07, 2025 BUSINESS WIRE Vensana Capital ("Vensana"), a leading venture capital and growth equity investment firm dedicated to medical technology, today announced the launch of Vensana Innovation ("VI"), a medtech innovation engine newly established by the firm. VI will be led by Thomas Tu, MD, a highly respected clinician and seasoned medtech executive who has joined Vensana as a Venture Partner after years of close collaboration with the Vensana team during his tenure as Chief Medical Officer at Inari Medical. Vensana Innovation's mission is to identify, develop, and commercialize novel medical technologies that address significant unmet clinical needs. VI's development model provides entrepreneurs and management teams with funding, resources, expertise, and guidance to transform breakthrough concepts into successful products and companies. Opportunities will span internally generated insights, physician- or inventor-led collaboration, emerging com
Show less
Read more
Impact Snapshot
Event Time:
CVRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CVRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CVRX alerts
High impacting CVRx, Inc. news events
Weekly update
A roundup of the hottest topics
CVRX
News
- CVRx to Participate at the Piper Sandler 37th Annual Healthcare ConferenceGlobeNewswire
- With 41% stake, CVRx, Inc. (NASDAQ:CVRX) seems to have captured institutional investors' interest [Yahoo! Finance]Yahoo! Finance
- CVRx (NASDAQ:CVRX) had its price target raised by analysts at Canaccord Genuity Group Inc. from $9.00 to $11.00. They now have a "buy" rating on the stock.MarketBeat
- CVRx (NASDAQ:CVRX) had its price target raised by analysts at Cantor Fitzgerald from $11.00 to $13.00. They now have an "overweight" rating on the stock.MarketBeat
- CVRx Inc (CVRX) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic Expansions [Yahoo! Finance]Yahoo! Finance
CVRX
Earnings
- 11/5/25 - Beat
CVRX
Sec Filings
- 12/1/25 - Form 4
- 11/25/25 - Form 4
- 11/17/25 - Form DEL
- CVRX's page on the SEC website